Effect of L arginine on epilepsy
Phase 3
- Conditions
- epilepsy.
- Registration Number
- IRCT201603078436N3
- Lead Sponsor
- eurology Research Center Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
inclusion : patients with epilepsy who have not responses to combination therapy(at least 2 attack per month) by antiepileptic drugs (at least 2 drugs);
Exclusion: any disorders except epilepsy; Neurologic disorder except epilepsy; Pregnancy; hypersensitivity or adverse events to L-rrginine
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of epileptic attacks. Timepoint: Duration of every attack in one month. Method of measurement: number.;Severity of attacks. Timepoint: duration every attack. Method of measurement: number.
- Secondary Outcome Measures
Name Time Method on-tolerance. Timepoint: 3 months. Method of measurement: report.